Request to Join
has invited you to join this group
The Philips Wearables Challenge is a call for novel solutions to predict early signs of patient deterioration and prevent hospital readmission. What cutting edge technologies and systems — wireless wearable sensors, connected devices, continuous, real-time monitoring, data analytics, etc. — can be deployed to facilitate early, appropriate interventions? How can they create actionable information to improve patient outcomes, without burying busy clinicians under too much data? (#PhilipsChallenge)
The Philips Wearables Challenge is a call for novel solutions to predict early signs of patient deterioration and prevent hospital readmission. What cutting edge technologies and systems — wireless wearable sensors, connected devices, continuous, real-time monitoring, data analytics, etc. — can...Read More
Since joining Boston Children’s, Carla has overseen the transition of the innovation program into the Innovation & Digital Health Accelerator (IDHA), a multi-disciplinary team that builds and scales market competitive digital health technologies.
"We have sharpened our focus on accelerating and commercializing the transformative ideas of Boston Children’s clinicians and researchers, but today we’re also making a strategic decision to expand our reach through partnerships with industry and startups." IDHA is translating Boston Children’s know-how into clinical decision support tools in partnership with Amazon, Withings, IBM Watson and GE, and is working with Rock Health to speed up the development of pediatric-focused digital health technologies.
Carla joined Boston Children’s in 2013, bringing extensive industry knowledge in health care, product development, and business strategy as a consultant to start-up, mid-cap and Fortune 500 companies, and an early stage employee at an IBM spinout company. She founded a health care strategy consulting firm, and before that was a consultant with Health Advances, consulting to medical device, biotechnology, pharmaceutical, diagnostic and direct-service health care providers. She also served on the Consumer Marketing Advisory Board for Medtronic Diabetes.
Carla is on the School Board for Codman Academy Charter Public School in Dorchester, MA. Previously, she worked at a startup, Work/Family Directions, where she launched a series of nationwide groundbreaking work-family benefits promoting a diverse, engaged workforce.
Carla received her MBA from the Harvard Business School and her undergraduate degree from Dartmouth College.
Working to accelerate innovation through healthcare and tech investments, acquisitions and strategic partnerships at the CVS Health Digital Innovation Lab. Previously worked to catalyze innovation at Brigham and Women’s Hospital in order to better position the institute to respond to the changing dynamics within healthcare and, prior to that, in biotechnology at Genetic Services, Inc. as Director of Operations.
Specialties: Business strategy, strategic partnerships, healthcare venture capital, corporate business development, healthcare/life science strategy, digital health strategy, joint ventures, healthcare technology transfer, operations/project management, general management, market research, “big data”, technology integration, health IT and telemedicine.
Meg is passionate about driving change by collaborating with physicians, technology leaders and solution innovators to improve health care. She has served in product development and business development leadership roles at the AMA and most recently is responsible for driving the roadmap of initiatives that support the AMA’s digital health and medicine strategy. In addition, she has led partnerships and innovation related initiatives, such as the inaugural AMA Healthier Nation Innovation Challenge, the establishment of the AMA Interaction Studio at MATTER and the beta AMA Physician Innovation Network that enables entrepreneurs and physicians to collaborate on the development of new solutions.
Judy Wang is the Digital Health Lead for Swiss Re's Digital Analytics Catalyst team. Prior to joining Swiss Re, she was the first Executive Director of Hacking Medicine Institute, a non-profit spinoff from MIT that aims to accelerate proof and adoption of effective new medical technologies. In this role, she oversaw the MIT Hacking Medicine student initiative, which brings together students and professionals interested in health care entrepreneurship and has produced 100+ healthcare innovation events around the world. Judy also served as the 2015-2016 Innovation Fellow with the Mayor's Office of New Urban Mechanics for the City of Boston, which serves as Mayor Martin J. Walsh's civic innovation group. Previously, Judy was a Program Manager for Hospital Telehealth Programs at Boston Children's Hospital, where she was responsible for the deployment and expansion of telehealth strategies across the Boston Children's Hospital Community of Care. Judy's previous posts also include entrepreneurial stints in San Francisco-based health tech startups Empower Interactive and Pipette, and graduate-level research work with the Military Health System and the Department of Defense. Judy holds an SM in Technology and Policy from the Massachusetts Institute of Technology and a BA in Molecular & Cell Biology and Psychology from the University of California, Berkeley. She currently resides in Boston, Mass. and served on the Mayor of Boston's ONEin3 Council, which works on projects dedicated to maximizing the positive impact that young people have on the City of Boston.
Specialties: business strategy, operations, technology policy, IT policy, system dynamics, public relations, social media, innovation & entrepreneurship, health care
David Binder is a physician at Spaulding Rehabilitation Hospital and Massachusetts General Hospital Orthopedic Spine Center in Boston, Massachusetts. Dr. Binder serves as the Director of Innovation for Spaulding Rehabilitation Hospital, Medical Director at Spaulding Cambridge Outpatient Center, and the Director of Spine Training for the Spaulding/Harvard sports medicine fellowship program. He is also the Vice-President of the medical staff at Spaulding.
As the Director of Innovation at Spaulding Rehabilitation Hospital, Dr. Binder focuses on promoting and developing internal innovation initiatives as well as forging external collaborations with partnering hospitals, universities, and innovators focused on advancing medicine and healthcare.
Gajen Sunthara is the Director of Innovation R&D at Boston Children's Hospital and is the founder of 1upHealth, which is an inclusive healthcare data platform for patients, providers and app developers. Prior to this, he helped tech-architect President Obama’s Precision Medicine Initiative at the White House, worked at The United States Digital Service (USDS), and served as a Presidential Innovation Fellow (PIF) at the U.S. Department of Health and Human Services/Office of the National Coordinator for Health IT. While in both public service roles, he worked with multiple government agencies including the U.S. Department of Defense (DoD), Veteran Affairs (VA), and the Centers for Medicare & Medicaid Services (CMS) on the national healthcare information exchange.
He also holds a Senior Advisor role at InciteHealth at the Center for Primary Care at Harvard Medical School.
Gajen has a B.Sc. in Computer Science from Wentworth Institute of Technology and a M.S. in Information Technology from Harvard University.
Getting her start at VA as a Presidential Innovation Fellow, Ms. Andrea Ippolito now leads the VA Innovators Network within the VA Center for Innovation. In this capacity, she designed and oversaw the creation of a program that provides the tools and resources to VA employees to develop innovations that improve the experience of our Veterans. The Innovators Network currently includes Innovation Specialists at twenty-two VA Medical Centers across VA. Through the Innovators Network, front line VA employees have designed, tested or launched more than 35 Veteran-centric innovations. She recently completed her role as a Presidential Innovation Fellow working with VA. Ms. Ippolito has pursued doctoral studies in the Engineering Systems Division at MIT and is the Co-Founder of an innovative application that improves access to care called Smart Scheduling (acquired by athenahealth in 2016). She also previously served as the Co-Director of MIT’s “Hacking Medicine” program, as an Innovation Specialist at the Brigham Innovation Hub and Product Innovation Manager at athenahealth. Ms. Ippolito completed her MS in Engineering & Management at MIT. Prior to MIT, Ms. Ippolito worked as a Research Scientist within the Corporate Technology Development group at Boston Scientific. She obtained both her BS in Biological Engineering in 2006 and Masters of Engineering in Biomedical Engineering in 2007 from Cornell University.
Dr. Gandhi is an entrepreneur, investor and resident physician in internal medicine at the Massachusetts General Hospital. Alongside his clinical duties, he engages in early-stage biopharmaceutical and healthcare IT investments at Excel Venture Management, a $175 million venture capital fund based in Boston, and he leads Wellable, an angel-backed mobile corporate wellness startup serving more than 45,000 members, also based in Boston.
Previously, he worked at McKinsey & Company, where he advised technology and pharmaceutical clients on strategy and marketing engagements, and at the TriZetto Corporation, where he developed new health insurance products aimed at incentivizing high-value care. His leadership extends to organized medicine, where he has served on the Boards of Trustees of the Massachusetts Medical Society and the Boston Medical Library as well as on the Executive Committee of the Suffolk Medical Society as its Secretary/Treasurer.
Shaan is a graduate of Harvard Medical School and of Harvard Business School, where he was a George F. Baker Scholar. He received his DPhil in medical oncology from the University of Oxford, where he was a Rhodes Scholar, and his BS with honors in biochemistry from Case Western Reserve University. At Oxford, he co-founded Health2Home, a mobile maternal health nonprofit in Uganda.
As Healthcare Innovation Lead for the TMC Innovation Institute, Arielle manages the development of all curriculum and programming for TMCx cohorts and Biodesign fellows. In this role, she plans all the sessions, lectures, panels, office hours, advisory sessions, and more. Arielle also oversees the Advisor Program and is regularly seeking out new people to engage with the TMC Innovation Institute. Before joining TMC in 2016, she was Senior Marketing Manager for North America at Withings based in Boston, where she was responsible for creating, implementing, and overseeing the comprehensive marketing campaigns for the entire line of Withings’ connected healthcare products up until they were acquired by Nokia. Prior to that, Arielle lived in Paris, France where she obtained her Master of Business Administration degree from Collège des Ingénieurs and worked at Sanofi as project manager for its global health & prevention program. Arielle received a Master of Public Health degree in Nutrition from Tufts University School of Medicine and during this time also interned at Boston Children’s Hospital’s OWL (Optimal Weight for Life) Clinic to help them build a physical activity resource guide for underprivileged obese children in the community. Arielle graduated cum laude from Tufts University with a B.S. degree in Psychology and Community Health during which she started the university’s on-campus farmer’s market and completed the 2010 Boston Marathon with the Tufts team. Arielle is passionate about educating people to live healthy lives through good nutrition & being physically active. In her spare time, she volunteers with local nutrition based non-profits – Brighter Bites, Recipe for Success, and the YMCA.
John S. Rumsfeld, MD, PhD, FACC is the Chief Innovation Officer for the American College of Cardiology (ACC), the 52,000 member non-profit professional association for cardiovascular clinicians in the U.S. and abroad. In this role, Dr. Rumsfeld is responsible for developing a long-term innovation agenda to help the ACC maintain its competitive advantage in the global marketplace, investigating global and domestic market trends in the delivery of cardiovascular care and health information technology, and exploring new technologies and team-based approaches to health care.
I am general internist, member of the MGH Core Educator Faulty and the co-Director the MGH Department of Medicine Resident Leadership Program. My areas of interest are physician leadership, resident education and innovation.
I am an emergency medicine physician and medical toxicologist at the Brigham and Women's Hospital and Harvard Medical School. My research focuses on the intersection of technology and health. I have led pilot deployments of wearable devices and smart glasses in the emergency department to detect and respond to worsening illness and substance abuse.
For a list of citations pleas see: http://www.ncbi.nlm.nih.gov/sites/myncbi/peter.chai.1/bibliography/47858651/public/?sort=date&direction= descending
Ravi is a Resident in Internal Medicine at Brigham and Women's Hospital. Originally from Hernando, Florida, he received his M.D. and M.P.P. from Harvard. His clinical and research interests are in aging, serious illness, big data, and cancer survivorship. He advises several nonprofits in the field of aging and advanced illness.
Dr. Majmudar is a practicing cardiologist and Associate Director of the Healthcare Transformation Lab at Massachusetts General Hospital, and an Instructor at Harvard Medical School. He is an active member of the healthcare innovation and entrepreneurship community, with a specific interest in technology-enabled healthcare innovation. He was a founding member and chief clinical officer of Quanttus, Inc. a venture-backed medical wearables startup. He is also a lecturer in the Harvard-MIT HST Program, and co-faculty for the course Healthcare Ventures.
As the Senior Director of Connected Health Innovation, Dr. Jethwani is responsible for leading a multidisciplinary team to identify and solve challenges in health care delivery using innovative technology-based solutions. As an organization that is embracing value-based reimbursement across all care settings, his solutions enable improved outcomes by making care delivery a continuous function of patients’ lives. His team is engaged in needs assessments across the system, product development and evaluations, as well as rigorous research to prove the value and outcomes of using connected health solutions. These innovations are routinely scaled within clinical practices at Partners, and made part of the usual care provided to patients.
Brownstein was trained as an epidemiologist at Yale University, where he received his PhD. Dr. Brownstein’s research interests are in the development of methods and data sources in public health informatics which focuses on two major areas: (1) the design, evaluation and implementation of public health surveillance systems and (2) statistical modeling of public health surveillance data to improve prevention and control activities. This research has focused on a variety of infectious disease systems including malaria, HIV, dengue, West Nile virus, Lyme disease, RSV, salmonella, listeria and influenza. Current research activities focus on predicting patterns of influenza epidemics and pandemics, with specific interests in the efficacy of disease control strategies including vaccination, quarantine and travel restrictions.
Leading strategy and business development for a new business at Philips Healthcare, focused on building the next generation of patient care for both in-hospital and out-of-hospital settings: Connected Sensing (areas of focus include medical-grade, connected wearables, telemedicine, IoT, big data/predictive analytics, machine learning).